About This Research Desk

What Peptide Bounce Balm is

Peptide Bounce Balm is an independent editorial research desk covering the published literature on two compounds at the intersection of skin biology and research peptides: GHK-Cu (copper tripeptide-1) and GLOW (the co-formulated GHK-Cu + BPC-157 + TB-500 blend). The site exists to make a scattered, often overstated literature legible — to tell a reader, in plain language and with citations, what each compound was actually studied for, in which species, and how far that evidence really extends.

The desk leads with GHK-Cu because it has the deepest and most peer-reviewed record of the two. GLOW sits alongside it not because it has equivalent evidence, but because understanding what a single-constituent study does and does not establish is exactly the right frame for reading a multi-constituent blend. The contrast between them is the point.

Each compound has its own page. A comparison page lines them up across the dimensions that matter for reading peptide research: molecule type, study context, evidence model, administration route, regulatory standing, and the one caution most worth knowing. A single shared references list aggregates every source cited across both.

How it is compiled

Three principles govern what appears on this desk.

First, everything is anchored to the peer-reviewed literature. Every research claim is tied to a numbered citation — PubMed-indexed journal articles and reviews, with DOIs or PubMed/PMC links — aggregated on the references page. Where a finding comes from a review rather than a primary study, the review is cited as the review, not the studies it summarizes.

Second, the evidence is reported at its true strength. Species and routes are always specified — for example, "studied at picomolar concentrations in human fibroblast cultures" or "studied in rats at a specific dose" — never scaled to humans or offered as a recommendation. Where evidence is preclinical, small-scale, concentrated in a single research group, or extrapolated from a parent molecule rather than the marketed compound, the page says so plainly. That candor is the design of the desk, not an afterthought.

Third, the two pages are cross-referenced. Because the GLOW blend borrows much of its evidence from GHK-Cu, and because the angiogenesis mechanism of BPC-157 links back to GHK-Cu's own vascular effects, the pages link to one another so a reader can trace a mechanism from one entry to the next without losing the thread.

What it is not

Peptide Bounce Balm is not a store, not a clinic, and not a source of medical advice. It does not sell, supply, source, or broker any peptide or research chemical. It has no affiliate or referral relationship with any vendor. It does not employ clinicians, diagnose any condition, or recommend any course of action.

The compounds discussed here are research peptides. Topical copper tripeptide-1 (GHK-Cu) is a legal cosmetic ingredient in several jurisdictions, but injectable or systemic GHK-Cu is unapproved. The GLOW blend and its injectable constituents are not approved medicines; several of those constituents are explicitly prohibited in sport. The value this desk offers is an accurate map of a complicated literature — nothing more, and nothing it pretends to be. Readers with clinical questions should consult a licensed clinician in their own jurisdiction.